# Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Cancer

> **NCT03615170** · — · UNKNOWN · sponsor: **Zhejiang Cancer Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Rectal Neoplasms
- Neoadjuvant Therapy
- Circulating Tumor DNA

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03615170
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-07-19
- **Primary completion:** 2020-03-30
- **Final completion:** 2022-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03615170

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03615170, "Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03615170. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*